Rani Therapeutics Holdings RANI
NASDAQ RANI
$0.81 +0.01 (+1.81%)
As of: Oct 2, 2026 · 12:01 PM EDT

Rani Therapeutics Holdings (RANI) Depreciation & Amortization (CF) (2020 - 2026)

Updated

Rani Therapeutics Holdings' Depreciation & Amortization (CF) came in at $152,000 for Q2 2026, down 36.7% from $240,000 a year earlier and down 5.6% from the prior quarter.

Analysis

Rani Therapeutics Holdings (RANI) Depreciation & Amortization (CF) (2020 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Rani Therapeutics Holdings reported Depreciation & Amortization (CF) of $722,000, down 28.9% year-over-year; for FY2025, it came in at $900,000, down 12.5% from FY2024.

  • Depreciation & Amortization (CF) carries a five-year compound annual growth rate of 8.4% (FY2020 to FY2025).
  • Going back by year, Depreciation & Amortization (CF) was $1.03 million in FY2024 (+25.1%), $822,000 in FY2023 (+50.0%), $548,000 in FY2022 (+10.3%) and $497,000 in FY2021 (-17.2%).
  • The Q2 2026 figure represents the lowest quarterly Depreciation & Amortization (CF) since Q3 2022.
  • Year-over-year, Depreciation & Amortization (CF) has declined for five consecutive quarters, with an average decline of 10.6% over the last eight quarters.
  • The fastest year-over-year change in Depreciation & Amortization (CF) over five years came in Q1 2023 (growth of 69.4%), and the weakest in Q2 2026 (a decline of 36.7%).
  • Business Quant data shows RANI's Depreciation & Amortization (CF) at $161,000 (Q1 2026), $186,000 (Q4 2025) and $223,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.96 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 194.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.93 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 98.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.62 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 56.50 Mn
10 Rani Therapeutics Holdings 147.86 Mn 156.61 Mn - 152,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 152,000.00
Mar 31, 2026 161,000.00
Dec 31, 2025 186,000.00
Sep 30, 2025 223,000.00
Jun 30, 2025 240,000.00
Mar 31, 2025 251,000.00
Dec 31, 2024 266,000.00
Sep 30, 2024 259,000.00
Jun 30, 2024 255,000.00
Mar 31, 2024 248,000.00
Dec 31, 2023 227,000.00
Sep 30, 2023 218,000.00
Jun 30, 2023 189,000.00
Mar 31, 2023 188,000.00
Dec 31, 2022 174,000.00
Sep 30, 2022 141,000.00
Jun 30, 2022 122,000.00
Mar 31, 2022 111,000.00
Dec 31, 2021 113,000.00
Sep 30, 2021 120,000.00
API Access

Rani Therapeutics Holdings Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=RANI&period=max&api_key=YOUR_API_KEY